Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Henin E et al. – The authors highlight the effect of three parameters on the quality of compliance estimates based on limited pharmacokinetic information: the plasma elimination half–life, interdose interval and magnitude of the error model. Nevertheless, the pharmacokinetic method is not informative enough and should be used with electronic monitoring, which provides additional information on compliance. This method will be used in a future phase IV clinical trial where the relationships between compliance, efficacy and tolerability will be assessed.

Related Articles

Anticancer Chemotherapy Inhibits MHC Class I–Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
Cancer Research, 10/21/09    Relevance Score: 85%

Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience
Expert Review of Vaccines, 10/08/09    Relevance Score: 85%

ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09    Relevance Score: 84%

Promising Novel Treatment For Human Cancer Chrysanthemum Indicum Extract
ScienceDaily, 10/19/09    Relevance Score: 84%

Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09    Relevance Score: 84%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address